A placebo-controlled study of three agomelatine dose regimens (10 mg, 25 mg, 25-50 mg) in patients with major depressive disorder. (Q48351011)
Jump to navigation
Jump to search
scientific article published on 31 January 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A placebo-controlled study of three agomelatine dose regimens (10 mg, 25 mg, 25-50 mg) in patients with major depressive disorder. |
scientific article published on 31 January 2014 |
Statements
A placebo-controlled study of three agomelatine dose regimens (10 mg, 25 mg, 25-50 mg) in patients with major depressive disorder (English)
Alla Avedisova
Natalia Giménez-Montesinos
Carole Belaïdi
Christian de Bodinat
Agomelatine Study Group